Bloomberg -- Ranbaxy Laboratories Ltd., the Indian drugmaker battling falling sales after the U.S. barred some of its drugs, said it expects the Food and Drug Administration to respond “very soon” regarding the ban.
Bloomberg -- Ranbaxy Laboratories Ltd., the Indian drugmaker battling falling sales after the U.S. barred some of its drugs, said it expects the Food and Drug Administration to respond “very soon” regarding the ban.
